Form 15-12G Y-mAbs Therapeutics,

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 001-38650  

 

Y-MABS THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)

 

202 Carnegie Center, Suite 301

Princeton, New Jersey 08540

(646) 885-8505

(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

 

Common Stock, par value $0.0001 per share

(Title of each class of securities covered by this Form)

 

None

(Title of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)	x
Rule 12g-4(a)(2)	¨
Rule 12h-3(b)(1)(i)	x
Rule 12h-3(b)(1)(ii)	¨
Rule 15d-6	¨
Rule 15d-22(b)	¨

 

Approximate number of holders of record as of the certification or notice date:  One

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Y-mAbs Therapeutics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person. 

 

	Y-MABS THERAPEUTICS, INC.
September 26, 2025	By:	/s/ Vanessa Wolfeler
	Name: Vanessa Wolfeler
	Title: President

 

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Ping An Ranks 48th on 2026 Fortune Global 500 List, Marking 17th Consecutive Year on List
• PK MED Strengthens Its Strategic and Scientific Governance to Support the Development of Its Therapeutic Micro-implants
• AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata